What this trial studies
This study aimed to assess the impact of laughter yoga intervention on symptomatology and quality of life among postmenopausal women.The research was conducted in a randomized controlled experimental design.
Conditions in scope
- Menopause
Interventions
- Laughter yoga (Other) — The women in the experimental group were given laughter yoga sessions by the researcher.
Who can join
Women only · Ages 45 Years and up · Accepts healthy volunteers.
Inclusion criteria
- Entering natural menopause,
- Being over 45 years old,
- Being at least a primary school graduate (in order to be able to fill out the forms),
- Agreeing to participate in the research voluntarily,
- Not having any hearing or vision problems (in order to be able to perform the sessions),
- No diagnosed psychiatric disease,
- Knowing Turkish,
- Having a smart mobile phone
Exclusion criteria
- Not continuing with laughter yoga sessions.
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Yakutiye | Erzurum | Ayşe Aydın | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Interventional
- Phase: N/A
- Start date: 2023-08-25
- Primary completion: 2023-12-15
- Last update posted: 2025-12-17
- First posted: 2024-08-30
Sponsor & contact
Lead sponsor: Ataturk University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Personal Information Form (5 months)
It consists of 10 questions (age, gender, education level, marital status, income status, etc.) prepared by the researcher in line with the literature. - Menopause Rating Scale (5 months)
The scale, which includes a total of 11 items including menopausal complaints, consists of 3 sub-dimensions. These sub-dimensions are 1-Somatic complaints sub-dimension (items 1,2,3,11), 2-Psychological complaints sub-dimension (items 4,5,6,7), 3-Urogenital complaints sub-dimension (8,9, Article 10). The scale is a 5-point Likert type and each statement is scored as 0: None, 1: Mild, 2: Moderate, 3: Severe and 4: Very severe.… - Menopause-Specific Quality of Life Scale (5 months)
It is a Likert type scale containing 29 questions. It consists of four subdomains: vasomotor domain (questions 1-3), psychosocial domain (questions 4-10), physical domain (questions 11-26) and sexual domain (questions 27-29). The complaints that women have experienced in the last month are questioned and the answers to the questions are "yes" or "no". In MÖYÖS, each subdomain score is ranked…
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06579118 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.